Articles Posted in Featured Lawsuits

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many victims want to know what spinal cord stimulator settlement amounts will look like and how we think compensation will be calculated, assuming an ultimate settlement. Settlement amounts and payouts in these cases will depend on several factors, which we dig into more fully below.

By Ronald V. Miller, Jr. Miller & Zois represents survivors of sexual abuse. Our attorneys include partner Laura G. Zois, who handles sexual assault lawsuits.

Roblox lawsuits are being filed by families who allege predators used the platform to groom, manipulate, exploit, or gain access to minors. These child sexual abuse and exploitation cases challenge years of Roblox branding itself as a safe place for children to create and play. Plaintiffs contend that its safety systems did not match that promise.

Federal lawsuits filed around the country allege that Roblox failed to protect minors from foreseeable exploitation and grooming risks. Most of these individual cases are now coordinated in the Roblox MDL in the Northern District of California, Case No. 25-md-03166-RS, before Chief Judge Richard Seeborg.

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media lawsuits, including the upcoming trial in California and the federal social media addiction MDL.

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, TikTok, and YouTube. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, self-harm, and, in some cases, suicide.

Now, these companies are facing a wave of lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.


By Ronald V. Miller, Jr.
  Miller & Zois has extensive experience representing survivors of sexual abuse. Our attorneys include partner Laura G. Zois, who handles sexual assault lawsuits.

Uber is defending thousands of sexual assault lawsuits brought by passengers who say they were sexually assaulted by Uber drivers. Plaintiffs are asking what Uber knew about the risk of sexual assault, how it screened drivers, what happened when complaints came in, and whether the company could have done more to keep dangerous drivers off the platform.

In February 2026, a federal jury awarded $8.5 million to a woman who alleged she was raped by an Uber driver. The jury found Uber liable under an apparent-agency theory, although it rejected separate claims involving Uber’s negligence and the design of its safety systems. The verdict was a significant victory for plaintiffs, but it also showed that the legal theory used to establish Uber’s liability can matter enormously.

Our lawyers are reviewing hair relaxer cancer lawsuits for women across the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation included 12,381 pending lawsuits as of October 1, 2026. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. This litigation has been going on for years, but there is still no global hair relaxer settlement or MDL payout program.  That does not mean our lawyers are not bullish on these cases. We are. It is just moving slowly, which is how it goes sometimes in the MDL mass torts. We still expect a favorable global settlement when all is said and done.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

Our lawyers are now focusing our attention on the Medtronic Bravo CF capsule recall.

This device is used to diagnose acid reflux and gastroesophageal reflux disease (GERD). In September 2026, the FDA classified a major recall of these devices as Class I, the agency’s most serious recall category.

This should be a simple no-frills test. A doctor attaches a small capsule to the lining of the patient’s esophagus. The capsule measures acidity and transmits readings to a receiver the patient wears. The goal is to determine whether the patient has acid reflux.

Chlorpyrifos lawsuits allege that repeated exposure to this widely used insecticide can contribute to Parkinson’s disease. The people most likely to bring these claims are farmers, pesticide applicators, pest control workers, groundskeepers, greenhouse employees, and others who personally mixed, loaded, sprayed, or cleaned up chlorpyrifos products over months or years.

Chlorpyrifos (CPF) was sold under trade names that include Dursban, Lorsban, Cobalt, Nufos, Bolton, Stallion, Pilot, Warhawk, and Hatchet. It was used on farms, golf courses, ornamental plants, and residential and commercial properties. Many workers remember the trade name but not the active ingredient. Product identification is therefore one of the first and most important parts of investigating a claim.

Quick answers

Our lawyers are primarily investigating gambling addiction lawsuits involving DraftKings and FanDuel.

These lawsuits revolve around the idea that these companies had the data to identify compulsive gambling behavior. Did they use that data to protect gambling addicts or did they use this information to target them?

No, just the opposite. Instead of slowing vulnerable users down, DraftKings, FanDuel, and other defendants allegedly saw them as cash cow targets and pushed bonus bets, deposit matches, and anything else they could to keep them addicted and burning money on their betting apps. So the issue at trial is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died from these medical scopes.

What happened?  These awful infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat.

So you had patients who went to the hospital, often getting diagnostic or therapeutic procedures that they did not think would be a big deal, only to come out with infections that damaged organs, required months of intensive care, or, tragically, proved fatal.

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas.

On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, COPD, and a host of other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different and not one they could have expected.

Contact Information